GSDMD and Parkinson disease: Moreover, inhibition of GSDMD with DSF attenuates the bacterial infection-associated PD behavioral phenotype and dopaminergic neuron loss.459 These results suggest that GSDMD represents a promising new therapeutic target for PD, but further studies are needed to confirm its therapeutic potential and to elucidate the precise mechanisms underlying its action.